RHODES
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 22 Aug 2025)
What this means for you
Registered since 16 Apr 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87980230
- Registration number
- 5729905
- Mark type
- Design + words
- Filed
- 17 Aug 2017
- Published for opposition
- 26 Jun 2018
- Registered
- 16 Apr 2019
- Attorney of record
- Fara S. Sunderji
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of and symptomatic relief from pain, ADHD, asthma, opioid dependence, high cholesterol, depression, anxiety, anorexia, cachexia, and emesis
Owner
- RHODES PHARMACEUTICALS L.P., COVENTRY, RI, US
- Rhodes Pharmaceuticals L.P., Coventry, RI, US
- Rhodes Pharmaceuticals L.P., Coventry, RI, US
- Rhodes Pharmaceuticals L.P., Coventry, RI, US
Prosecution history
- 22 Aug 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 22 Aug 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 22 Aug 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 16 Apr 2025 — TEAS SECTION 8 & 15 RECEIVED
- 16 Apr 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 29 Jul 2020 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 16 Apr 2019 — REGISTERED-PRINCIPAL REGISTER
- 21 Mar 2019 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 15 Mar 2019 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 14 Mar 2019 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 14 Mar 2019 — STATEMENT OF USE PROCESSING COMPLETE
- 14 Feb 2019 — USE AMENDMENT FILED
- 14 Mar 2019 — DIVISIONAL PROCESSING COMPLETE
- 14 Feb 2019 — DIVISIONAL REQUEST RECEIVED
- 14 Mar 2019 — CASE ASSIGNED TO INTENT TO USE PARALEGAL